The Theory of Tumor Ecosystem

Overview

Journal Cancer Commun (Lond)

Publisher Wiley

Specialty Oncology

Date 2022 Jun 1

PMID 35642770

Authors

Xueman Chen

Erwei Song

Affiliations

Soon will be listed here.

Abstract

Cancer cells can be conceived as "living organisms" interacting with cellular or non-cellular components in the host internal environment, not only the local tumor microenvironment but also the distant organ niches, as well as the immune, nervous and endocrine systems, to construct a self-sustainable tumor ecosystem. With increasing evidence for the systemic tumor-host interplay, we predict that a new era of cancer therapy targeting the ecosystemic vulnerability of human malignancies has come. Revolving around the tumor ecosystem scoped as different hierarchies of primary, regional, distal and systemic onco-spheres, we comprehensively review the tumor-host interaction among cancer cells and their local microenvironment, distant organ niches, immune, nervous and endocrine systems, highlighting material and energy flow with tumor ecological homeostasis as an internal driving force. We also substantiate the knowledge of visualizing, modelling and subtyping this dynamically intertwined network with recent technological advances, and discuss ecologically rational strategies for more effective cancer therapies.

Citing Articles

lncRNAs: the unexpected link between protein synthesis and cancer adaptation.

Gugnoni M, Kashyap M, Wary K, Ciarrocchi A Mol Cancer. 2025; 24(1):38.

PMID: 39891197 PMC: 11783725. DOI: 10.1186/s12943-025-02236-7.

Tumor microenvironment and immunotherapy for triple-negative breast cancer.

Guo Z, Zhu Z, Lin X, Wang S, Wen Y, Wang L Biomark Res. 2024; 12(1):166.

PMID: 39741315 PMC: 11689763. DOI: 10.1186/s40364-024-00714-6.

Regulation of metastatic organotropism.

Dunbar K, Efe G, Cunningham K, Esquea E, Navaridas R, Rustgi A Trends Cancer. 2024; 11(3):216-231.

PMID: 39732596 PMC: 11903188. DOI: 10.1016/j.trecan.2024.11.012.

Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.

Mayasin Y, Osinnikova M, Kharisova C, Kitaeva K, Filin I, Gorodilova A Cells. 2024; 13(22).

PMID: 39594665 PMC: 11592585. DOI: 10.3390/cells13221917.

A computational analysis of the oncogenic and anti-tumor immunity role of P4HA3 in human cancers.

Huang H, Zhang F, Yu J, Xiao Y, Zhu D, Yi X PLoS Comput Biol. 2024; 20(11):e1012284.

PMID: 39504328 PMC: 11573185. DOI: 10.1371/journal.pcbi.1012284.

References

McLaughlin M, Patin E, Pedersen M, Wilkins A, Dillon M, Melcher A . Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Cancer. 2020; 20(4):203-217. DOI: 10.1038/s41568-020-0246-1. View

Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M . Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007; 109(9):3812-9. DOI: 10.1182/blood-2006-07-035972. View

Amersi F, Terando A, Goto Y, Scolyer R, Thompson J, Tran A . Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res. 2008; 14(3):638-45. PMC: 2760931. DOI: 10.1158/1078-0432.CCR-07-2025. View

Jackson H, Fischer J, Zanotelli V, Ali H, Mechera R, Soysal S . The single-cell pathology landscape of breast cancer. Nature. 2020; 578(7796):615-620. DOI: 10.1038/s41586-019-1876-x. View

Hanoteau A, Newton J, Krupar R, Huang C, Liu H, Gaspero A . Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. J Immunother Cancer. 2019; 7(1):10. PMC: 6332704. DOI: 10.1186/s40425-018-0485-9. View

Schreiber R, Old L, Smyth M . Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011; 331(6024):1565-70. DOI: 10.1126/science.1203486. View

Govaert K, Emmink B, Nijkamp M, Cheung Z, Steller E, Fatrai S . Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells. Ann Surg. 2013; 259(4):750-9. DOI: 10.1097/SLA.0b013e318295c160. View

Mishra P, Banerjee D, Ben-Baruch A . Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol. 2010; 89(1):31-9. DOI: 10.1189/jlb.0310182. View

Courtiol P, Maussion C, Moarii M, Pronier E, Pilcer S, Sefta M . Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med. 2019; 25(10):1519-1525. DOI: 10.1038/s41591-019-0583-3. View

10.

Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J . Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019; 567(7747):249-252. PMC: 6430113. DOI: 10.1038/s41586-019-1004-y. View

11.

Sanchez-Correa B, Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Bergua J . DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy. Cancers (Basel). 2019; 11(6). PMC: 6628015. DOI: 10.3390/cancers11060877. View

12.

Keeley T, Costanzo-Garvey D, Cook L . Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer. Trends Cancer. 2019; 5(12):789-798. DOI: 10.1016/j.trecan.2019.10.013. View

13.

Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y . Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019; 21(4):498-510. DOI: 10.1038/s41556-019-0299-0. View

14.

Watson M, Vignali P, Mullett S, Overacre-Delgoffe A, Peralta R, Grebinoski S . Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021; 591(7851):645-651. PMC: 7990682. DOI: 10.1038/s41586-020-03045-2. View

15.

Mueller M, Fusenig N . Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004; 4(11):839-49. DOI: 10.1038/nrc1477. View

16.

Song X, Chang S, Seminario-Vidal L, Pulido A, Tordesillas L, Song X . Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma. Cancer Discov. 2022; 12(5):1294-1313. PMC: 9148441. DOI: 10.1158/2159-8290.CD-21-1207. View

17.

Kather J, Poleszczuk J, Suarez-Carmona M, Krisam J, Charoentong P, Valous N . Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer. Cancer Res. 2017; 77(22):6442-6452. DOI: 10.1158/0008-5472.CAN-17-2006. View

18.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View

19.

Maley C, Aktipis A, Graham T, Sottoriva A, Boddy A, Janiszewska M . Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer. 2017; 17(10):605-619. PMC: 5811185. DOI: 10.1038/nrc.2017.69. View

20.

van Dongen J, Bartelink H, Fentiman I, Lerut T, Mignolet F, Olthuis G . Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 1992; 28A(4-5):801-5. DOI: 10.1016/0959-8049(92)90118-l. View